{"canonical":"https://abierto.us/opportunities/75n95024q00433","key":"75N95024Q00433","url":"https://abierto.us/opportunities/75n95024q00433","title":"High-throughput Cell Analysis System","solicitation_number":"75N95024Q00433","notice_type":"a","open":false,"response_deadline":"2024-08-30T18:00:00Z","first_posted":"2024-07-12","last_posted":"2024-09-25","department":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","subagency":"NATIONAL INSTITUTES OF HEALTH","office":"NATIONAL INSTITUTES OF HEALTH NIDA","naics":"334516","psc":"6640","set_aside":null,"place_state":"DE","place_county":"10003","place_county_name":"New Castle County","place_city":"1077580","place_city_name":"Wilmington","winner":"AGILENT TECHNOLOGIES INC","award_amount":"139313.00","publications":[{"notice_id":"781a6ffc9e0b4508ad8abfa7fafe6571","title":"High-throughput Cell Analysis System","solicitation_number":"75N95024Q00433","notice_type":"r","base_type":"r","posted":"2024-07-12","posted_at":null,"due_at":"2024-07-22T18:00:00Z","due_date":"2024-07-22","cancelled":null,"archived":null,"archive_date":"2024-08-06","award_number":null,"awardee_name":null,"amount":null,"link_sam":"https://sam.gov/workspace/contract/opp/781a6ffc9e0b4508ad8abfa7fafe6571/view","enriched":false,"history":[]},{"notice_id":"13ff6921e6f6489c87b9db1272a97b87","title":"High-throughput Cell Analysis System","solicitation_number":"75N95024Q00433","notice_type":"k","base_type":"r","posted":"2024-08-26","posted_at":null,"due_at":"2024-08-30T18:00:00Z","due_date":"2024-08-30","cancelled":null,"archived":null,"archive_date":"2024-09-14","award_number":null,"awardee_name":null,"amount":null,"link_sam":"https://sam.gov/workspace/contract/opp/13ff6921e6f6489c87b9db1272a97b87/view","enriched":false,"history":[]},{"notice_id":"7fa1ae6219154d78af8d20bb43a671eb","title":"High-throughput Cell Analysis System","solicitation_number":"75N95024P00641","notice_type":"a","base_type":"k","posted":"2024-09-25","posted_at":null,"due_at":null,"due_date":null,"cancelled":null,"archived":null,"archive_date":"2024-10-03","award_number":"75N95024P00641","awardee_name":"AGILENT TECHNOLOGIES INC Wilmington","amount":"139313.00","link_sam":"https://sam.gov/workspace/contract/opp/7fa1ae6219154d78af8d20bb43a671eb/view","enriched":false,"history":[]}],"latest_notice_id":"7fa1ae6219154d78af8d20bb43a671eb","first_type":"r","notices":[{"dates":{"posted":"2024-07-12","response_deadline":{"raw":"2024-07-22T14:00:00-04:00","utc":"2024-07-22T18:00:00Z","date":"2024-07-22","time":"14:00:00","utc_offset_seconds":-14400}},"links":{"sam":"https://sam.gov/workspace/contract/opp/781a6ffc9e0b4508ad8abfa7fafe6571/view"},"naics":{"codes":["334516"],"primary":"334516"},"title":"High-throughput Cell Analysis System","agency":{"office":{"code":"75N950","name":"NATIONAL INSTITUTES OF HEALTH NIDA"},"subtier":{"code":"7529","name":"NATIONAL INSTITUTES OF HEALTH"},"department":{"code":"075","name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF"},"office_address":{"zip":"20892","city":"Bethesda","state":"MD","country":"USA"},"organization_type":"OFFICE"},"status":{"active":false,"archive_date":"2024-08-06","archive_type":"auto15"},"contacts":[{"name":"Tracy Cain","role":"primary","email":"tracy.cain@nih.gov","phone":"3014436677"},{"name":"Josh Lazarus","role":"secondary","email":"josh.lazarus@nih.gov","phone":"3018276923"}],"base_type":{"code":"r","label":"Sources Sought"},"notice_id":"781a6ffc9e0b4508ad8abfa7fafe6571","provenance":{"extract":{"url":"https://s3.amazonaws.com/falextracts/Contract%20Opportunities/Archived%20Data/FY2024_archived_opportunities.csv","etag":"\"d582488fe153a9f11bf629913d176ffc-137\"","fetched_at":"2026-09-16T19:07:39.720164Z","row_sha256":"6aaaa37e892f5f117e0d5a0c4f421c6427e759cc6307afcf1f5e959408c2014b","last_modified":"2026-09-13T14:47:40Z"},"updated_at":"2026-09-16T19:07:39.720164Z","first_seen_at":"2026-09-16T19:07:39.720164Z"},"description":{"text":"This is a Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding the availability and capability of all qualified sources to perform a potential requirement. This notice is issued to help determine the availability of qualified companies under the NAICS Code 334516 - Analytical Laboratory Instrument Manufacturing, technically capable of meeting the Government requirement, to determine the method of acquisition, and availability of domestic sources manufactured in the United States in sufficient and reasonably available commercial quantities and of a satisfactory quality. It is not to be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. Responses will not be considered as proposals or quotes. No award will be made as a result of this notice. The Government will NOT be responsible for any costs incurred by the respondents to this notice. This notice is strictly for research and information purposes only. Small businesses are encouraged to respond. For equipment/supply requirements, responses must include the place of manufacturing (i.e. address if supply/equipment is a domestic end product and include country of manufacture). For equipment/supply requirements, small businesses must also address the size status of the manufacturer under the applicable NAICS code (i.e. address Non-Manufacturer Rule). Statement of Need and Purpose: The NeuroTherapeutics Development Unit (NTDU) Translational Neuroscience (TNC) National Institute of Neurological Disorderes and Stropke (NINDS) requires the purchase of a high throughput cell analysis system with equivalment capabilities to the Agilent xCELLigence RTCA HT system to facilitate the screening and evaluation of toxicities to neurons and other cells following exposure to chemotoxic agents, toxic proteins and viral infections. Purchase Description: NIDA requires a brand-name or equal system to the xCELLigence RTCA HT system, consisting of an xCELLigence RTCA SP analyzer and Biospag-SN automated incubator with associated peripherals and software to complement pre-existing instruments for develop new therapeutic agents, to treat neuro degeneration and infectious diseases in the human brain. The system must have equivalent capabilities to the following: Agilent xCELLigence RTCA SP, which analyzes live cells in a 384-well format. Comes bundled with analyzer, plate station, and control unit with software, cat# 380601070 Automated incubator with 8-plate capacity, incubation to 45degC, and CO2 /O2 control and monitoring, water pan and humidity monitoring. Incl. BioSpa software and one alignment kit.Rep. BTI no. BIOSPAG, cat# Biospag-SN ACCESS FLUIDICS ALIGN, Cat# 1410011 RTCA-HT BioSpa Integration package, cat# S2812AA Salient characteristics: NIDA requires a High-Throughput Cell Analysis System with the following brand-name or equal salient characteristics: Capable of cell analysis of up to eight 384-well E-plates (a total of 3,072 wells) with non-invasive and label-free real-time impedance technology Kinetic measurement of cell health, viability, or response to treatments with high sensitivity, accuracy, and reproducibility, providing a continuous flow of real-time data. Automated workflow which allows users to add cells to E-Plates 384 and begin kinetic measurements at physiological conditions. The BioSpa8 Robotic Arm transfers plates from the incubator to the xCELLigence RTCA HT Station to enable. multiple plates to be processed while unattended. Critical physiological conditions are controlled and maintained in the incubator to ensure assay success. Temperature and CO2/O2 control, plus humidity monitoring in the incubator facilitate live cell processes, and the cradle of the RTCA HT unit is temperature-controlled, for minimal disruption of the cells. The software continuously records environmental conditions. Software allows for simple assay setup (scheduling) for both single and multiple users, real-time data visualization, and data analysis. Capable of high throughput screening of therapeutic antibodies, drug compounds, and cytotoxicity. Typical applications to include Compound-mediated cytotoxicity assay; Viral-mediated cytopathic effect (CPE); Neutralizing antibody screening; Antiviral drug screening; Immune cell potency assay; Antibody-dependent cell-mediated cytotoxicity (ADCC) assays. Quantity: 1 x xCELLigence RTCA SP analyzes live cells in a 384-well format. Comes bundled with analyzer, plate station, and control unit with software, cat# 380601070 1X Automated incubator with 8-plate capacity, incubation to 45degC, and CO2 /O2 control and monitoring, water pan and humidity monitoring. Incl. BioSpa software and one alignment kit.Rep. BTI no. BIOSPAG, cat# Biospag-SN 1X ACCESS FLUIDICS ALIGN, Cat# 1410011 1X RTCA-HT BioSpa Integration package, cat# S2812AA Delivery Date: Delivery shall occur within 30-60 days after receipt of order. Capability Statement /Information Sought: Companies that believe they possess the capabilities to provide the required products or services should submit documentation of their ability to meet each of the project requirements to the Contracting Officer. The capability statement must specifically address each of the project requirements separately. Additionally, the capability statement should include 1) the total number of employees, 2) the professional qualifications of personnel as it relates to the requirements outlined, 3) any contractor GSA Schedule contracts and/or other government-wide acquisition contracts (GWACs) by which all of the requirements may be met, if applicable, and 4) any other information considered relevant to this program. Capability statements must also include the Company Name, Unique Entity ID from SAM.gov, Physical Address, and Point of Contact Information. The response must include the respondents’ technical and administrative points of contact, including names, titles, addresses, telephone and fax numbers, and e-mail addresses. Interested companies are required to identify their type of business, applicable North American Industry Classification System (NAICS) Code, and size standards in accordance with the Small Business Administration. The government requests that no proprietary or confidential business data be submitted in a response to this notice. However, responses that indicate the information therein is proprietary will be properly safeguarded for Government use only. Capability statements must include the name and telephone number of a point of contact having authority and knowledge to discuss responses with Government representatives. Capability statements in response to this market survey that do not provide sufficient information for evaluation will be considered non-responsive. When submitting this information, please reference the solicitation notice number. Submission Instructions: The response is limited to ten (10) page limit. The 10-page limit does not include the cover page, executive summary, or references, if requested. All responses to this notice must be submitted electronically to the Contracting Officer Identified below. The response must be received on or before July 22, 2024, at 2:00 pm EST. Facsimile responses are NOT accepted. Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a presolicitation synopsis and solicitation may be published in www.sam.gov. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality: No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).” Closing Statement: THIS NOTICE IS NOT A REQUEST FOR COMPETITIVE PROPOSALS. However, interested parties may identify their interest and capability to respond to this notice. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. All responsible sources may submit a capability statement, proposal, or quotation which shall be considered by the agency. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Unique Entity ID (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. All responses must be received by the closing date and time of this announcement and must reference the solicitation number, 75N95024Q00433. Responses must be submitted electronically to Tracy Cain, Contracting Officer, at tracy.cain@nih.gov. Mail and Fax responses will not be accepted.","origin":"extract"},"notice_type":{"code":"r","label":"Sources Sought"},"schema_version":1,"solicitation_number":"75N95024Q00433","product_service_code":"6640"},{"dates":{"posted":"2024-08-26","response_deadline":{"raw":"2024-08-30T14:00:00-04:00","utc":"2024-08-30T18:00:00Z","date":"2024-08-30","time":"14:00:00","utc_offset_seconds":-14400}},"links":{"sam":"https://sam.gov/workspace/contract/opp/13ff6921e6f6489c87b9db1272a97b87/view"},"naics":{"codes":["334516"],"primary":"334516"},"title":"High-throughput Cell Analysis System","agency":{"office":{"code":"75N950","name":"NATIONAL INSTITUTES OF HEALTH NIDA"},"subtier":{"code":"7529","name":"NATIONAL INSTITUTES OF HEALTH"},"department":{"code":"075","name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF"},"office_address":{"zip":"20892","city":"Bethesda","state":"MD","country":"USA"},"organization_type":"OFFICE"},"status":{"active":false,"archive_date":"2024-09-14","archive_type":"auto15"},"contacts":[{"name":"Tracy Cain","role":"primary","email":"tracy.cain@nih.gov","phone":"3014436677"},{"name":"Josh Lazarus","role":"secondary","email":"josh.lazarus@nih.gov","phone":"3018276923"}],"base_type":{"code":"r","label":"Sources Sought"},"notice_id":"13ff6921e6f6489c87b9db1272a97b87","provenance":{"extract":{"url":"https://s3.amazonaws.com/falextracts/Contract%20Opportunities/Archived%20Data/FY2024_archived_opportunities.csv","etag":"\"d582488fe153a9f11bf629913d176ffc-137\"","fetched_at":"2026-09-16T19:07:39.720164Z","row_sha256":"b416a0be2f08ddbc555920264b5b254965e117c9bf0678243ad69e35f62b2779","last_modified":"2026-09-13T14:47:40Z"},"updated_at":"2026-09-16T19:07:39.720164Z","first_seen_at":"2026-09-16T19:07:39.720164Z"},"description":{"text":"This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; Quotes are being requested and a separate written solicitation will not be issued. The solicitation number is 75N95024Q00433 and the solicitation is issued as request for quotation (RFQ). This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; and FAR Part 12—Acquisition of Commercial Items and is not expected to exceed the simplified acquisition threshold. The NeuroTherapeutics Development Unit (NTDU) Translational Neuroscience (TNC) National Institute of Neurological Disorders and Stroke (NINDS) requires the purchase of a high throughput cell analysis system with equivalent capabilities to the Agilent xCELLigence RTCA HT system to facilitate the screening and evaluation of toxicities to neurons and other cells following exposure to chemotoxic agents, toxic proteins and viral infections. The mission of the Translational Neuroscience Center, TNC/ Neurotherapeutic Development Unit (NTDU), is to identify, characterize and develop new therapeutic agents to treat neuro degeneration and infectious diseases in the human brain. Currently NTDU utilizes many modalities to develop new therapeutic agents, many of the models involve cell toxicity and different assays to determine the toxic activity of chemicals, proteins and viral infections. A novel approach is to incorporate the real time cell analysis provided by the xCELLigence RTCA HT system to facilitate compound screening in 384 well plate format. High-throughput real-time cell analysis is ideal for screening viral mediated cytopathic effects (CPE), neutralizing antibodies, antibody-dependent cytotoxicity (ADCC), and compound mediated cytotoxicity. The system will be used to quantitate the cell types following exposure to toxic chemicals, proteins, patient serum/plasma or cerebrospinal fluid or viral infections. The NTDU require the acquisition of an equivalent system to the xCELLigence RTCA HT system, consisting of an xCELLigence RTCA SP analyzer and Biospag-SN automated incubator with associated peripherals and software compatible with pre-existing instruments to develop new therapeutic agents, to treat neuro degeneration and infectious diseases in the human brain. This is a Brand Name or Equal requirement for an xCELLigence RTCA SP System with automated incubator and associated peripherals. The contractor must provide a system with equivalent capabilities to the following: The xCELLigence RTCA SP, which analyzes live cells in a 384-well format. Comes bundled with analyzer, plate station, and control unit with software, cat# 380601070 Automated incubator with 8-plate capacity, incubation to 45degC, and CO2 /O2 control and monitoring, water pan and humidity monitoring. Incl. BioSpa software and one alignment kit. Rep. BTI no. BIOSPAG, cat# Biospag-SN ACCESS FLUIDICS ALIGN, Cat# 1410011 RTCA-HT BioSpa Integration package, cat# S2812AA","origin":"extract"},"notice_type":{"code":"k","label":"Combined Synopsis/Solicitation"},"schema_version":1,"solicitation_number":"75N95024Q00433","product_service_code":"6640"},{"award":{"date":"2024-09-18","amount":"139313.00","number":"75N95024P00641","awardee":{"raw":"AGILENT TECHNOLOGIES INC Wilmington DE 19808 USA","name":"AGILENT TECHNOLOGIES INC Wilmington","location":{"zip":"19808","state":{"code":"DE"},"country":{"code":"USA"}}}},"dates":{"posted":"2024-09-25","award_date":"2024-09-18"},"links":{"sam":"https://sam.gov/workspace/contract/opp/7fa1ae6219154d78af8d20bb43a671eb/view"},"naics":{"codes":["334516"],"primary":"334516"},"title":"High-throughput Cell Analysis System","agency":{"office":{"code":"75N950","name":"NATIONAL INSTITUTES OF HEALTH NIDA"},"subtier":{"code":"7529","name":"NATIONAL INSTITUTES OF HEALTH"},"department":{"code":"075","name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF"},"office_address":{"zip":"20892","city":"Bethesda","state":"MD","country":"USA"},"organization_type":"OFFICE"},"status":{"active":false,"archive_date":"2024-10-03","archive_type":"auto15"},"contacts":[{"name":"Tracy Cain","role":"primary","email":"tracy.cain@nih.gov","phone":"3014436677"},{"name":"Josh Lazarus","role":"secondary","email":"josh.lazarus@nih.gov","phone":"3018276923"}],"base_type":{"code":"k","label":"Combined Synopsis/Solicitation"},"notice_id":"7fa1ae6219154d78af8d20bb43a671eb","provenance":{"extract":{"url":"https://s3.amazonaws.com/falextracts/Contract%20Opportunities/Archived%20Data/FY2024_archived_opportunities.csv","etag":"\"d582488fe153a9f11bf629913d176ffc-137\"","fetched_at":"2026-09-16T19:07:39.720164Z","row_sha256":"c6c3e1afb6a86f7ba6bf256cf42ed1580d0f42b222c9745f0f1d6c9eebb72be6","last_modified":"2026-09-13T14:47:40Z"},"updated_at":"2026-09-16T19:07:39.720164Z","first_seen_at":"2026-09-16T19:07:39.720164Z"},"description":{"text":"On September 18, 2024; in response to the requirements of Solicitation 75N95024Q00433, the National Institute on Drug Abuse (NIDA) awarded a Purchase Order No. 75N95024P00641 to Agilent Technologies, Inc. to provide a a high-throughput cell analysis system and automated incubator. An award shall be made on a Firm-Fixed-Price basis. Funding in the amount $139,313.00 shall be obligated to fully fund this award.","origin":"extract"},"notice_type":{"code":"a","label":"Award Notice"},"schema_version":1,"solicitation_number":"75N95024P00641","product_service_code":"6640"}],"due_at":"2024-08-30T18:00:00Z","due_date":"2024-08-30","closes_at":"2024-08-30T18:00:00Z","awardable":false,"dept_key":"d-075","dept_name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","sub_key":"s-7529","sub_name":"NATIONAL INSTITUTES OF HEALTH","office_key":"o-75N950","office_name":"NATIONAL INSTITUTES OF HEALTH NIDA","state":"DE","county":"10003","county_name":"New Castle County","city":"1077580","city_name":"Wilmington","country":null,"winner_key":"SD9JZ9S7MEA6","amount":"139313.00","linked_awards":3,"cancelled":false,"archived":false,"updated_at":"2026-09-16T21:18:12.857524Z","principal_notice_id":"7fa1ae6219154d78af8d20bb43a671eb","description":{"text":"On September 18, 2024; in response to the requirements of Solicitation 75N95024Q00433, the National Institute on Drug Abuse (NIDA) awarded a Purchase Order No. 75N95024P00641 to Agilent Technologies, Inc. to provide a a high-throughput cell analysis system and automated incubator. An award shall be made on a Firm-Fixed-Price basis. Funding in the amount $139,313.00 shall be obligated to fully fund this award.","html":null,"origin":"extract"},"contacts":[{"name":"Tracy Cain","role":"primary","email":"tracy.cain@nih.gov","phone":"3014436677"},{"name":"Josh Lazarus","role":"secondary","email":"josh.lazarus@nih.gov","phone":"3018276923"}],"place_of_performance":null,"office_address":{"zip":"20892","city":"Bethesda","state":"MD","country":"USA"},"naics_codes":["334516"],"award":{"date":"2024-09-18","amount":"139313.00","number":"75N95024P00641","awardee":{"raw":"AGILENT TECHNOLOGIES INC Wilmington DE 19808 USA","name":"AGILENT TECHNOLOGIES INC Wilmington","location":{"zip":"19808","state":{"code":"DE"},"country":{"code":"USA"}}}},"attachments":[],"awards":[{"award_key":"CONT_AWD_75N95024P00641_7529_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N95024P00641_7529_-NONE-_-NONE-/","piid":"75N95024P00641","parent_piid":null,"award_type":"PURCHASE ORDER","vendor_key":"SD9JZ9S7MEA6","recipient_name":"AGILENT TECHNOLOGIES INC","recipient_uei":"SD9JZ9S7MEA6","recipient_cage":"0YSC6","recipient_city":"WILMINGTON","recipient_state":"DE","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NIDA","office_key":"o-75N950","first_action_date":"2024-09-18","last_action_date":"2024-09-18","actions":1,"obligated":"139313.00","current_total_value":"139313.00","potential_total_value":"139313.00","naics":"334516","psc":"6515","extent_competed":"COMPETED UNDER SAP","set_aside":"NO SET ASIDE USED.","offers_received":2,"description":"FY24. HIGH-THROUGHPUT CELL ANALYSIS SYSTEM AND AUTOMATED INCUBATOR","method":"piid","confidence":"high","evidence":["award number 75N95024P00641 equals the contract number","same awarding office 75N950"],"opportunity_key":null,"opportunity_title":null}],"related":[{"key":"75N98026R00157SB","latest_notice_id":"ee510f1cce674a259b707473c3e23234","title":"CTN Data, Statistics, and Clinical Trial Support Center (DSC7)","solicitation_number":"75N98026R00157SB","notice_type":"r","first_type":"r","first_posted":"2026-09-09","last_posted":"2026-09-09","notices":1,"due_at":"2026-09-30T17:00:00Z","due_date":"2026-09-30","closes_at":"2026-09-30T17:00:00Z","awardable":true,"open":true,"dept_key":"d-075","dept_name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","sub_key":"s-7529","sub_name":"NATIONAL INSTITUTES OF HEALTH","office_key":"o-75N950","office_name":"NATIONAL INSTITUTES OF HEALTH NIDA","naics":"541715","psc":"AN11","set_aside":"SBA","state":null,"county":null,"county_name":null,"city":null,"city_name":null,"country":null,"winner":null,"winner_key":null,"amount":null,"linked_awards":0,"cancelled":false,"archived":false,"updated_at":"2026-09-16T21:18:12.857524Z"},{"key":"75N98026R00157OT","latest_notice_id":"a367c8ec486d4b1fa7709ac1c2c6e019","title":"CTN Data, Statistics, and Clinical Trial Support Center (DSC7)","solicitation_number":"75N98026R00157OT","notice_type":"r","first_type":"r","first_posted":"2026-09-09","last_posted":"2026-09-09","notices":1,"due_at":"2026-09-30T17:00:00Z","due_date":"2026-09-30","closes_at":"2026-09-30T17:00:00Z","awardable":true,"open":true,"dept_key":"d-075","dept_name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","sub_key":"s-7529","sub_name":"NATIONAL INSTITUTES OF HEALTH","office_key":"o-75N950","office_name":"NATIONAL INSTITUTES OF HEALTH NIDA","naics":"541715","psc":"AN11","set_aside":null,"state":null,"county":null,"county_name":null,"city":null,"city_name":null,"country":null,"winner":null,"winner_key":null,"amount":null,"linked_awards":0,"cancelled":false,"archived":false,"updated_at":"2026-09-16T21:18:12.857524Z"},{"key":"75N95026R00003","latest_notice_id":"180e97fe5cab4693b99f561c5ede9778","title":"Data Access Program","solicitation_number":"75N95026R00003","notice_type":"p","first_type":"p","first_posted":"2025-12-15","last_posted":"2025-12-15","notices":2,"due_at":"2026-12-30T18:00:00Z","due_date":"2026-12-30","closes_at":"2026-12-30T18:00:00Z","awardable":true,"open":true,"dept_key":"d-075","dept_name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","sub_key":"s-7529","sub_name":"NATIONAL INSTITUTES OF HEALTH","office_key":"o-75N950","office_name":"NATIONAL INSTITUTES OF HEALTH NIDA","naics":"541611","psc":"R499","set_aside":null,"state":null,"county":null,"county_name":null,"city":null,"city_name":null,"country":null,"winner":null,"winner_key":null,"amount":null,"linked_awards":0,"cancelled":false,"archived":false,"updated_at":"2026-09-16T21:18:12.857524Z"}]}